Variables | Cohort 1 (N = 364) | Cohort 2 (N = 1142) | p value |
---|---|---|---|
n (%) | n (%) | Â | |
Diagnosis | Â | Â | Â |
UA | 68 (18.7) | 157 (13.7) | 0.021* |
NSTEMI | 85 (23.4) | 389 (34.1) | < 0.001* |
STEMI | 211 (60.0) | 594 (52.0) | 0.047* |
Treatment and outcome | Â | Â | Â |
Intrahospital pharmacotherapy | Â | Â | Â |
ASA/aspirin | 320 (87.9) | 1118 (97.9) | < 0.001* |
Clopidogrel | 308 (84.6) | 1086 (95.1) | < 0.001* |
Statin | 271 (74.5) | 1112 (97.4) | < 0.001* |
Anticoagulant | 168 (46.2) | 1047 (91.7) | < 0.001* |
Invasive treatment | Â | Â | Â |
Thrombolysis | 13 (3.6) | 163 (14.3) | < 0.001* |
PCI - Primary PCI - Rescue PCI | 34 (9.2) 10 (2.7) 2 (0.6) | 220 (19.2) 72 (6.3) 16 (1.4) | < 0.001* 0.009* 0.196 |
Time from onset to admission (hours) β | 24 (9–48) | 13 (6–33) | < 0.001* |
Time from admission to intervention (hours) β | 120 (8–168) | 19.58 (13.2–81.4) | < 0.001* |
Duration in hospital (days) β | 7 (5–10) | 6 (5–7) | 0.002* |
In-hospital mortality | 46 (12.6) | 66 (5.8) | < 0.001* |